Filed March 28, 2025

Serial No. 99108590

Examining Attorney LAURA KRISTEN TARABAN

Class Small molecule pharmaceuticals for the treatment of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, pain, peripheral neuropathy, inflammatory disease, autoimmune disease, ulcerative colitis, atopic dermatitis, plaque psoriasis, chronic obstructive pulmonary disease, Crohn's disease, eosinophilic esophagitis, systemic lupus erythematosus, multiple sclerosis, age-related diseases in the nature of Huntington's Disease, rare diseases in the nature of Lysosomal storage disorders, Peroxisomal disorders, Transthyretin Amyloid Cardiopathy (ATTR-CM), Alpha-1 Antitrypsin Deficiency (AATD), ENPP1 deficiency and vitamin D-dependent rickets diseases (VDDR), and pediatric diseases in the nature of Medulloblastoma, Pediatric Acute Lymphoblastic Leukemia (ALL) in humans; 005; 006; 018; 044; 046; 051; 052

Case Type Trademark